Cargando…

Diagnosis of Crohn’s disease and ulcerative colitis using the microbiome

BACKGROUND: Inflammatory bowel disease (IBD) is a multifactorial chronic inflammatory disease resulting from dysregulation of the mucosal immune response and gut microbiota. Crohn's disease (CD) and ulcerative colitis (UC) are difficult to distinguish, and differential diagnosis is essential fo...

Descripción completa

Detalles Bibliográficos
Autores principales:	Kang, Da-Yeon, Park, Jong-Lyul, Yeo, Min-Kyung, Kang, Sang-Bum, Kim, Jin-Man, Kim, Ju Seok, Kim, Seon-Young
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2023
Materias:	Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10640746/ https://www.ncbi.nlm.nih.gov/pubmed/37951857 http://dx.doi.org/10.1186/s12866-023-03084-5

Ejemplares similares

Development of a Machine Learning Model to Distinguish between Ulcerative Colitis and Crohn’s Disease Using RNA Sequencing Data
por: Park, Soo-Kyung, et al.
Publicado: (2021)

Potential Oral Microbial Markers for Differential Diagnosis of Crohn’s Disease and Ulcerative Colitis Using Machine Learning Models
por: Kang, Sang-Bum, et al.
Publicado: (2023)

Reliability and Validity of Korean Version of Crohn's and Ulcerative Colitis Questionnaire-8
por: Kang, Sung-Goo, et al.
Publicado: (2022)

Differences in Immunophenotyping of Mucosal Lymphocytes Between Ulcerative Colitis and Crohn’s Disease
por: Lee, Heung Bum, et al.
Publicado: (1997)

The Human Mesenteric Lymph Node Microbiome Differentiates Between Crohn’s Disease and Ulcerative Colitis
por: Kiernan, Miranda G, et al.
Publicado: (2019)

Potential Salivary Markers for Differential Diagnosis of Crohn’s Disease and Ulcerative Colitis
por: Nijakowski, Kacper, et al.
Publicado: (2021)

Anemia is associated with the risk of Crohn’s disease, not ulcerative colitis: A nationwide population-based cohort study
por: Kang, Eun Ae, et al.
Publicado: (2020)

Comparison of sampling methods in assessing the microbiome from patients with ulcerative colitis
por: Kim, Dan, et al.
Publicado: (2021)

Carbohydrate Intake in the Etiology of Crohn's Disease and Ulcerative Colitis
por: Chan, Simon S. M., et al.
Publicado: (2014)

Assessment of disease activity by fecal immunochemical test in ulcerative colitis
por: Ryu, Dae Gon, et al.
Publicado: (2016)

Postoperative changes of manometry after restorative proctocolectomy in Korean ulcerative colitis patients
por: Oh, Se Heon, et al.
Publicado: (2017)

The microbiome of Crohn’s disease aphthous ulcers
por: O’Brien, Claire L., et al.
Publicado: (2018)

Crohn's disease and ulcerative colitis Surgical management
por: Wilkinson, A J
Publicado: (1996)

Mucosal Barrier in Ulcerative Colitis and Crohn's Disease
por: Dorofeyev, A. E., et al.
Publicado: (2013)

The safety of vedolizumab for ulcerative colitis and Crohn's disease
por: Colombel, Jean-Frédéric, et al.
Publicado: (2017)

Ulcerative Colitis and Crohn's Disease: Similarities and Distinctions
por: Sawyerr, Af M, et al.
Publicado: (1994)

Review of pregnancy in Crohn’s disease and ulcerative colitis
por: Laube, Robyn, et al.
Publicado: (2021)

Two-year delay in ulcerative colitis diagnosis is associated with anti-tumor necrosis factor alpha use
por: Kang, Ho Suk, et al.
Publicado: (2019)

Additive effect of probiotics (Mutaflor) on 5-aminosalicylic acid therapy in patients with ulcerative colitis
por: Park, Soo-Kyung, et al.
Publicado: (2022)

Comparison between Pediatric Crohn’s Disease and Ulcerative Colitis at Diagnosis in Korea: Results from a Multicenter, Registry-Based, Inception Cohort Study
por: Park, Sowon, et al.
Publicado: (2022)

Expressing the Differences between Crohn Disease and Ulcerative Colitis
por: Wijmenga, Cisca
Publicado: (2005)

The Changing Prognosis of Ulcerative Colitis and Crohn Disease by Decades
por: Korelitz, Burton I, et al.
Publicado: (2021)

Comparative Study of Intestinal Microbiome in Patients with Ulcerative Colitis and Healthy Controls in Korea
por: Do, Kyung-Hyo, et al.
Publicado: (2023)

Surgical Treatment of Crohn Colitis Involving More Than 2 Colonic Segments: Long-Term Outcomes From a Single Institution
por: Lee, Jong Lyul, et al.
Publicado: (2016)

Tofacitinib for ulcerative colitis: results of the prospective Dutch Initiative on Crohn and Colitis (ICC) registry
por: Biemans, Vince B. C., et al.
Publicado: (2020)

Plasma microRNA Profile Differentiates Crohn’s Colitis From Ulcerative Colitis
por: Netz, Uri, et al.
Publicado: (2018)

Increased Risk of Asymptomatic Gallstones in Patients With Ulcerative Colitis
por: Ha, Jung Hoon, et al.
Publicado: (2015)

Microbiome analysis reveals that Ralstonia is responsible for decreased renal function in patients with ulcerative colitis
por: Kim, Jung Min, et al.
Publicado: (2021)

The ClC-2 Chloride Channel Activator, Lubiprostone, Improves Intestinal Barrier Function in Biopsies from Crohn’s Disease but Not Ulcerative Colitis Patients
por: Park, Young Su, et al.
Publicado: (2023)

Coexistence of Solitary Rectal Ulcer Syndrome and Ulcerative Colitis: A Case Report and Literature Review
por: Park, Hyun Bum, et al.
Publicado: (2014)

Artificial Intelligence Algorithm-Based Differential Diagnosis of Crohn's Disease and Ulcerative Colitis by CT Image
por: Jiang, Fangyun, et al.
Publicado: (2022)

Changes in fecal metabolic and lipidomic features by anti-TNF treatment and prediction of clinical remission in patients with ulcerative colitis
por: Kim, Seok-Young, et al.
Publicado: (2023)

Recurrent Mesalazine-Induced Myopericarditis in a Patient with Ulcerative Colitis
por: Park, Eun Hye, et al.
Publicado: (2012)

Comparative effectiveness of second-line biological therapies for ulcerative colitis and Crohn’s disease in patients with prior failure of anti-tumour necrosis factor treatment
por: Hyun, Hye Kyung, et al.
Publicado: (2022)

Combined Hepatic and Splenic Abscesses in a Patient with Ulcerative Colitis
por: Ji, Jeong-Seon, et al.
Publicado: (2007)

Clinical implications of fecal calprotectin and fecal immunochemical test on mucosal status in patients with ulcerative colitis
por: Ryu, Dae Gon, et al.
Publicado: (2019)

Is there a role for vedolizumab in the treatment of ulcerative colitis and Crohn’s disease?
por: Gilroy, Leah, et al.
Publicado: (2014)

Gastritis Associated with Initially Pediatric Crohn's Disease and Ulcerative Colitis
por: Basturk, Ahmet, et al.
Publicado: (2018)

Crohn’s Disease and Ulcerative Colitis Show Unique Cytokine Profiles
por: Nemeth, Zoltan H, et al.
Publicado: (2017)

Tofacitinib, two-faced Janus in ulcerative colitis and Crohn’s disease?
por: Biemans, Vince BC, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_a2nuu9r0spb3baqqroeido979i